Lynn K Wagner, MD Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 106 N Wisconsin St, De Pere, WI 54115 Phone: 920-327-7056 |
News Archive
MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market and the Hercules Market of the Osaka Securities Exchange, today reported positive preliminary results from a Phase Ib clinical trial to evaluate the safety and efficacy of MN-221 in patients with stable, moderate to severe chronic obstructive pulmonary disease (COPD). There were no clinically significant safety concerns noted. Preliminary results demonstrated clinically significant improvements in percent change in forced expiratory volume in one second (FEV(1)).
How cool is this: the Massachusetts General Hospital laboratory that invented cryolipolisis or "Coolsculpting," a popular non-surgical method for reducing fat under the skin, is developing a new form of the technology that can selectively reduce fat almost anywhere in the body using a safe, injectable ice solution or "slurry."
Making the time to take care of your body and fulfill your needs becomes increasingly more difficult with the pressures and stresses of a demanding schedule, fast-paced job and the increasing number of distractions around us.
Trimetazidine administered after successful percutaneous coronary intervention (PCI) does not improve outcomes in patients with chronic or acute coronary syndromes, according to results of the ATPCI trial presented in a Hot Line session today at ESC Congress 2020.
› Verified 9 days ago